Genmab A/S's market cap is currently kr130.43B. The company's EPS TTM is kr34.585516201; its P/E ratio is 15.32; Genmab A/S is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is kr29.97. See an overview of income statement, balance sheet, and cash flow financials.
